337 related articles for article (PubMed ID: 31060557)
1. Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review.
Kip MMA; Currie G; Marshall DA; Grazziotin Lago L; Twilt M; Vastert SJ; Swart JF; Wulffraat N; Yeung RSM; Benseler SM; IJzerman MJ;
Pediatr Rheumatol Online J; 2019 May; 17(1):20. PubMed ID: 31060557
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
[TBL] [Abstract][Full Text] [Related]
3. Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis.
Thornton J; Lunt M; Ashcroft DM; Baildam E; Foster H; Davidson J; Gardner-Medwin J; Beresford MW; Symmons D; Thomson W; Elliott RA
Rheumatology (Oxford); 2008 Jul; 47(7):985-90. PubMed ID: 18417528
[TBL] [Abstract][Full Text] [Related]
4. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
[TBL] [Abstract][Full Text] [Related]
5. The direct and indirect costs of Dravet Syndrome.
Whittington MD; Knupp KG; Vanderveen G; Kim C; Gammaitoni A; Campbell JD
Epilepsy Behav; 2018 Mar; 80():109-113. PubMed ID: 29414539
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
7. Costs of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System.
Kip MMA; de Roock S; van den Berg I; Currie G; Marshall DA; Grazziotin LR; Twilt M; Yeung RSM; Benseler SM; Vastert SJ; Wulffraat N; Swart JF; IJzerman MJ
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1585-1592. PubMed ID: 33938161
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of Juvenile Idiopathic Arthritis: a systematic review.
García-Rodríguez F; Gamboa-Alonso A; Jiménez-Hernández S; Ochoa-Alderete L; Barrientos-Martínez VA; Alvarez-Villalobos NA; Luna-Ruíz GA; Peláez-Ballestas I; Villarreal-Treviño AV; de la O-Cavazos ME; Rubio-Pérez N
Pediatr Rheumatol Online J; 2021 Oct; 19(1):152. PubMed ID: 34627296
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of the CAREGIVERS questionnaire: multi-assessing the impact of juvenile idiopathic arthritis on caregivers.
Torres-Made MD; Peláez-Ballestas I; García-Rodríguez F; Villarreal-Treviño AV; Fortuna-Reyna BJ; de la O-Cavazos ME; Rubio-Pérez NE
Pediatr Rheumatol Online J; 2020 Jan; 18(1):3. PubMed ID: 31937332
[TBL] [Abstract][Full Text] [Related]
10. Economic Burden of Juvenile Idiopathic Arthritis in India.
Khatun M; Datta D; Hazra A; Ghosh P; Selim MB; Mondal R
Indian Pediatr; 2021 Jan; 58(1):38-40. PubMed ID: 33034299
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Reed SD; Li Y; Leal J; Radican L; Adler AI; Alfredsson J; Buse JB; Green JB; Kaufman KD; Riefflin A; Van de Werf F; Peterson ED; Gray AM; Holman RR;
Diabetes Obes Metab; 2018 Jul; 20(7):1732-1739. PubMed ID: 29573215
[TBL] [Abstract][Full Text] [Related]
12. [The cost of schizophrenia: a literature review].
Charrier N; Chevreul K; Durand-Zaleski I
Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
Shepherd J; Cooper K; Harris P; Picot J; Rose M
Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
[TBL] [Abstract][Full Text] [Related]
14. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis.
Epps H; Ginnelly L; Utley M; Southwood T; Gallivan S; Sculpher M; Woo P
Health Technol Assess; 2005 Oct; 9(39):iii-iv, ix-x, 1-59. PubMed ID: 16181565
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study.
Grazziotin LR; Currie G; Twilt M; Ijzerman MJ; Kip MMA; Koffijberg H; Benseler SM; Swart JF; Vastert SJ; Wulffraat NM; Yeung RSM; Johnson N; Luca NJ; Miettunen PM; Schmeling H; Marshall DA;
Rheumatol Ther; 2021 Sep; 8(3):1303-1322. PubMed ID: 34275124
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database.
Minden K; Niewerth M; Listing J; Möbius D; Thon A; Ganser G; Ermisch-Omran B; Zink A
Clin Exp Rheumatol; 2009; 27(5):863-9. PubMed ID: 19917175
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of juvenile idiopathic arthritis.
Bernatsky S; Duffy C; Malleson P; Feldman DE; St Pierre Y; Clarke AE
Arthritis Rheum; 2007 Feb; 57(1):44-8. PubMed ID: 17266088
[TBL] [Abstract][Full Text] [Related]
18. Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review.
Kim NV; McErlean G; Yu S; Kerridge I; Greenwood M; Lourenco RA
Transplant Cell Ther; 2024 May; 30(5):542.e1-542.e29. PubMed ID: 38331192
[TBL] [Abstract][Full Text] [Related]
19. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
20. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
